Preview Mode Links will not work in preview mode

DeviceAlliance: MedTech Radio

Nov 2, 2020

Deerfield Management and Stan Rowe created a therapeutic device incubator, NXT Biomedical.  NXT Biomedical expects to invest up to $25 million in cutting edge technologies over the next 5 years.  Deerfield has allotted up to an additional $250 million for the formation and development of five to eight startup companies that emerge from the incubator.  NXT Biomedical provides an exciting new pathway for exceptional science to be incubated with the world-renowned leadership while continuing to address major unmet needs with next-generation medical technologies.

In this episode of DeviceAlliance’s Medtech Radio, we speak with the Co-Founder & CEO of NXT Biomedical, Stan Rowe.  Stan recently retired from Edwards Lifesciences where he was Chief Scientific Officer since 2008 and also served as Corporate Vice President, Advanced Technology.  He joined in 2004 when Edwards acquired Percutaneous Valve Technologies, a company he helped to found in 1999 and served as President and CEO.  Join us as we discuss Stan's life lessons learned in the Medtech industry, including...

- What are the biggest mistakes R&D makes
- Growing a company in his bedroom to being acquired
- Biggest strategic considerations for innovation
- Different types of accelerators
- Addressing the future of unmet clinical needs